Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
5
×
boston blog main
boston top stories
national blog main
national top stories
new york blog main
cancer
clinical trials
national
new york top stories
san francisco blog main
san francisco top stories
autoimmune diseases
biotech ipos
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
immunotherapy
indiana blog main
indiana top stories
investing
medicare
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
stem cell
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
What
market
5
×
medicine
patients
biotech
drug
new
raised
series
therapies
advantages
areas
arrival
bar
based
benefiting
bio
boston
brings
cambridge
cancer
cell
closed
coming
companies
date
days
development
diagnostics
eisai
expect
fda
february
flags
follows
gamble
glimcher
groundbreaking
hasn’t
headline
higher
Language
unset
Current search:
market
×
biotech
×
" life sciences "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@techcrunch.com
4 years ago
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September